{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:49:08Z","timestamp":1790801348330,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.micpath.2025.107361","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T11:05:19Z","timestamp":1738321519000},"page":"107361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii"],"prefix":"10.1016","volume":"200","author":[{"given":"Elijah Kolawole","family":"Oladipo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3405-9314","authenticated-orcid":false,"given":"Stephen Feranmi","family":"Adeyemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glory Jesudara","family":"Oluwasanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Oluwadarasimi","family":"Adaramola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalom Busayo","family":"Akintola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Oluwatobi","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel Damilare","family":"Ajagbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadara Hannah","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Pelumi","family":"Kolapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Owoeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Moradeyo","family":"Jimah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ademola O.","family":"Ayeleso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Onyeaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.micpath.2025.107361_bib1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/vaccines9060570","article-title":"Mapping global prevalence of Acinetobacter baumannii and recent vaccine development to tackle it","volume":"9","author":"Ma","year":"2021","journal-title":"Vaccines"},{"issue":"31","key":"10.1016\/j.micpath.2025.107361_bib2","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24651","article-title":"Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.micpath.2025.107361_bib3","doi-asserted-by":"crossref","DOI":"10.34133\/2020\/2016201","article-title":"The strategies of pathogen-oriented therapy on circumventing antimicrobial resistance","author":"Shang","year":"2020","journal-title":"Research"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib4","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"BioMed Res. Int."},{"issue":"15","key":"10.1016\/j.micpath.2025.107361_bib5","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.3390\/cancers15153942","article-title":"Cellular adaptation takes advantage of atavistic regression programs during carcinogenesis","volume":"15","author":"Gnocchi","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib6","doi-asserted-by":"crossref","DOI":"10.4161\/viru.19700","article-title":"Acinetobacter baumannii: an emerging opportunistic pathogen","volume":"3","author":"Howard","year":"2012","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mlf2.12078","article-title":"Roadmap to tackle antibiotic resistance in the environment under the One Health framework","volume":"2","author":"Li","year":"2023","journal-title":"Mlife"},{"issue":"10","key":"10.1016\/j.micpath.2025.107361_bib9","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/00006454-200010001-00008","article-title":"Antibiotic and antiseptic resistance: impact on public health","volume":"19","author":"Levy","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.micpath.2025.107361_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00433-22","article-title":"Acinetobacter metabolism in infection and antimicrobial resistance","volume":"91","author":"Ren","year":"2023","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.micpath.2025.107361_bib87","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41579-020-0340-0","article-title":"Critical analysis of antibacterial agents in clinical development","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107361_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.107361_bib13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/IDR.S166750","article-title":"Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities","author":"Asif","year":"2018","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Ayoub Moubareck","year":"2020","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1586\/14787210.6.3.309","article-title":"Acinetobacter baumannii: an emerging multidrug-resistant threat","volume":"6","author":"Gootz","year":"2008","journal-title":"Expert Rev. Anti-infect. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2289769","article-title":"Pathogenicity and virulence of Acinetobacter baumannii: factors contributing to the fitness in healthcare settings and the infected host","volume":"15","author":"Lucidi","year":"2024","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.micpath.2025.107361_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.02310-18","article-title":"Bacterial cytological profiling as a tool to study mechanisms of action of antibiotics that are active against Acinetobacter baumannii","volume":"63","author":"Htoo","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.107361_bib18","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/biomedicines10092219","article-title":"Combination strategies of different antimicrobials: an efficient and alternative tool for pathogen inactivation","volume":"10","author":"Basavegowda","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.micpath.2025.107361_bib19","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/molecules25122888","article-title":"Resistance of gram-positive bacteria to current antibacterial agents and overcoming approaches","volume":"25","author":"Jubeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2025.107361_bib20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3389\/fmicb.2019.01601","article-title":"The mechanisms of disease caused by Acinetobacter baumannii","volume":"10","author":"Morris","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107361_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107083","article-title":"A systematic review of peptide nucleic acids (PNAs) with antibacterial activities: efficacy, potential and challenges","author":"El-Fateh","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.micpath.2025.107361_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijantimicag.2016.01.015","article-title":"Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii","volume":"47","author":"Lob","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2025.107361_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2023.1110125","article-title":"Multidrug-resistant Acinetobacter baumannii in healthcare settings in Africa","volume":"4","author":"Agyepong","year":"2023","journal-title":"Frontiers in Tropical Diseases"},{"key":"10.1016\/j.micpath.2025.107361_bib25","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.4c00218","article-title":"A review of antibacterial candidates with new modes of action","author":"Butler","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107361_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215528","article-title":"Novel advancements in the sustainable green synthesis approach of silver nanoparticles (AgNPs) for antibacterial therapeutic applications","volume":"499","author":"Vadakkan","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.micpath.2025.107361_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115564","article-title":"Combatting resistance: understanding multi-drug-resistant pathogens in intensive care units","volume":"167","author":"Teng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2025.107361_bib28","series-title":"Integrative Approaches to Biotechnology","first-page":"93","article-title":"Plant thionins: the green antimicrobial agents","author":"Pandey","year":"2024"},{"issue":"4","key":"10.1016\/j.micpath.2025.107361_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acsinfecdis.3c00624","article-title":"Peptide dendrimer-based antibacterial agents: synthesis and applications","volume":"10","author":"Paul","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107361_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1040841X.2024.2369948","article-title":"Current and novel therapies for management of Acinetobacter baumannii-associated pneumonia","author":"Shein","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.14649","article-title":"The future of antibiotics begins with discovering new combinations","volume":"1496","author":"Zhu","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2025.107361_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/antibiotics13060506","article-title":"Antibiotic treatment of carbapenem-resistant Acinetobacter baumannii infections in view of the newly developed \u03b2-lactams: a narrative review of the existing evidence","volume":"13","author":"Serapide","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib33","first-page":"11","article-title":"Monotherapy versus combination therapy as treatment of multidrug-resistant Acinetobacter baumannii infections","volume":"11","author":"Caballero Torres","year":"2024","journal-title":"Revista Virtual de la Sociedad Paraguaya de Medicina Interna"},{"issue":"5","key":"10.1016\/j.micpath.2025.107361_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02710-21","article-title":"A novel triple combination to combat serious infections with carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model","volume":"10","author":"Al-Madboly","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.micpath.2025.107361_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac092","article-title":"Novel combination therapy for extensively drug-resistant Acinetobacter baumannii necrotizing pneumonia complicated by empyema: a case report","volume":"9","author":"Holger","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107361_bib36","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.4c00160","article-title":"Deciphering the intracellular action of the antimicrobial peptide A11 via an in-depth analysis of its effect on the global proteome of Acinetobacter baumannii","author":"Thitirungreangchai","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"9","key":"10.1016\/j.micpath.2025.107361_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1099\/jmm.0.000144","article-title":"Combined therapy for multi-drug-resistant Acinetobacter baumannii infection\u2013is there evidence outside the laboratory?","volume":"64","author":"Tuon","year":"2015","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib38","article-title":"Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia","volume":"11","author":"Jung","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107361_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkae191","article-title":"A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii","author":"Zhang","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2025.107361_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116269","article-title":"Enhancing the stability and therapeutic potential of the antimicrobial peptide Feleucin-K3 against Multidrug-Resistant A. baumannii through rational utilization of a D-amino acid substitution strategy","volume":"225","author":"An","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107361_bib41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12602-023-10066-6","article-title":"The synthetic antimicrobial peptide derived from melittin displays low toxicity and anti-infectious properties","volume":"16","author":"Rad","year":"2024","journal-title":"Probiotics and Antimicrobial Proteins"},{"key":"10.1016\/j.micpath.2025.107361_bib42","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.3389\/fmicb.2017.02659","article-title":"Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant Acinetobacter baumannii in mice","volume":"8","author":"Hua","year":"2018","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107361_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-021-06690-6","article-title":"Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals","volume":"48","author":"Ibrahim","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"7","key":"10.1016\/j.micpath.2025.107361_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13070680","article-title":"Synergistic antimicrobial effects of phage vB_AbaSi_W9 and antibiotics against Acinetobacter baumannii infection","volume":"13","author":"Choi","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00253-024-13208-0","article-title":"A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia","volume":"108","author":"Li","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107361_bib46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/antibiotics13070610","article-title":"Isolation and characterization of novel bacteriophages to target carbapenem-resistant Acinetobacter baumannii","volume":"13","author":"Choi","year":"2024","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib47","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1038\/s41467-022-31455-5","article-title":"Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.micpath.2025.107361_bib48","first-page":"1254","article-title":"Isolation, characterization, and effectiveness of bacteriophage P\u0278-Bw-Ab against XDR Acinetobacter baumannii isolated from nosocomial burn wound infection","volume":"24","author":"Rahimzadeh Torabi","year":"2021","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"10.1016\/j.micpath.2025.107361_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104045","article-title":"Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study","volume":"80","author":"Gordillo Altamirano","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.micpath.2025.107361_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2023.10.029","article-title":"Alginate microbeads and hydrogels delivering meropenem and bacteriophages to treat Pseudomonas aeruginosa fracture-related infections","volume":"364","author":"Chen","year":"2023","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-10081-0","article-title":"Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii","volume":"24","author":"Rastegar","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12879-024-09471-1","article-title":"Study of MIC of silver and zinc oxide nanoparticles, strong and cost-effective antibacterial against biofilm-producing Acinetobacter baumannii in Shiraz, Southwest of Iran","volume":"24","author":"Kakian","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12011-019-01962-6","article-title":"The efficacy of imipenem conjugated with synthesized silver nanoparticles against Acinetobacter baumannii clinical isolates, Iran","volume":"197","author":"Zendegani","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"issue":"11","key":"10.1016\/j.micpath.2025.107361_bib54","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/jcpt.13787","article-title":"Acinetobacter baumannii: pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline","volume":"47","author":"Dehbanipour","year":"2022","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"5","key":"10.1016\/j.micpath.2025.107361_bib55","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.8341","article-title":"Comparison of the antibacterial effects of nanosilver with 18 antibiotics on multidrug resistance clinical isolates of Acinetobacter baumannii","volume":"6","author":"Niakan","year":"2013","journal-title":"Jundishapur J. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02373-z","article-title":"Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii","volume":"22","author":"Lan","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.micpath.2025.107361_bib57","first-page":"1","article-title":"Polysaccharide-based hydrogels: properties, advantages, challenges, and optimization methods for applications in regenerative medicine","author":"Safarzadeh Kozani","year":"2021","journal-title":"International Journal of Polymeric Materials and Polymeric Biomaterials"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12879-024-09522-7","article-title":"Evaluating the antibacterial effect of meropenem-loaded chitosan\/sodium tripolyphosphate (TPP) nanoparticles on Acinetobacter baumannii isolated from hospitalized patients","volume":"24","author":"Amini","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107361_bib59","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.2147\/IDR.S328788","article-title":"Antibiotics combinations and chitosan nanoparticles for combating multidrug resistance Acinetobacter baumannii","volume":"14","author":"Banoub","year":"2021","journal-title":"Infect. Drug Resist."},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib60","doi-asserted-by":"crossref","first-page":"lxae046","DOI":"10.1093\/jambio\/lxae046","article-title":"The synergic and addictive activity of biogenic silver nanoparticle associated with meropenem against carbapenem-resistant Acinetobacter baumannii","volume":"135","author":"Allend","year":"2024","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib61","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1038\/s41598-024-53441-1","article-title":"Ciprofloxacin and levofloxacin-loaded nanoparticles efficiently suppressed fluoroquinolone resistance and biofilm formation in Acinetobacter baumannii","volume":"14","author":"Aboelenin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.107361_bib62","article-title":"Hypothetical adhesin CAM87009. 1 formulated in alum or biogenic silver nanoparticles protects mice from lethal infection by multidrug-resistant Acinetobacter baumannii","author":"de Freitas","year":"2024","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12088-023-01136-y","article-title":"Antibacterial potential of biosynthesized silver nanoparticles using berberine extract against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"64","author":"Tahan","year":"2024","journal-title":"Indian J. Microbiol."},{"key":"10.1016\/j.micpath.2025.107361_bib76","article-title":"Antibacterial activity evaluation of a novel K3-specific phage against Acinetobacter baumannii and evidence for receptor-binding domain transfer across morphologies","author":"Zheng","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.micpath.2025.107361_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1447301","article-title":"Trematocine-derived antimicrobial peptides from the Antarctic fish Trematomus bernacchaii: potent antibacterial agents against ESKAPE pathogens","volume":"15","author":"Squitieri","year":"2024","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2025.107361_bib78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","volume":"23","author":"Kaye","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107361_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106184","article-title":"Anti-capsular activity of CuO nanoparticles against Acinetobacter baumannii produces an efflux pump","volume":"181","author":"Al-Kadmy","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107361_bib80","article-title":"The phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study","volume":"80","author":"Altamirano","year":"2022","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.micpath.2025.107361_bib81","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/pharmaceutics13111800","article-title":"Development of novel peptides for the antimicrobial combination therapy against carbapenem-resistant Acinetobacter baumannii infection","volume":"13","author":"Choi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/v14010033","article-title":"Preclinical assessment of bacteriophage therapy against experimental acinetobacter baumannii lung infection","volume":"14","author":"Wienhold","year":"2021","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.micpath.2025.107361_bib83","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3390\/polym13091529","article-title":"Synergistic antibacterial effect of casein-AgNPs combined with tigecycline against Acinetobacter baumannii","volume":"13","author":"Chen","year":"2021","journal-title":"Polymers"},{"issue":"10","key":"10.1016\/j.micpath.2025.107361_bib84","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.107361_bib85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","article-title":"Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing","volume":"7","author":"Tsai","year":"2016","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.micpath.2025.107361_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2023.06.007","article-title":"The intracellular life of Acinetobacter baumannii","volume":"31","author":"Maure","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2025.107361_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126722","article-title":"An overview of Acinetobacter baumannii pathogenesis: motility, adherence and biofilm formation","volume":"247","author":"Mea","year":"2021","journal-title":"Microbiol. Res."},{"issue":"10","key":"10.1016\/j.micpath.2025.107361_bib66","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2217\/fmb-2020-0032","article-title":"Host-pathogen interactions in Acinetobacter baumannii infection: recent advances and future challenges","volume":"15","author":"Chen","year":"2020","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107361_bib67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01110-18","article-title":"New treatment options against carbapenem-resistant Acinetobacter baumannii infections","volume":"63","author":"Isler","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2025.107361_bib68","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/molecules26092671","article-title":"New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives","volume":"26","author":"Terreni","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.micpath.2025.107361_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11095-020-02849-1","article-title":"Bioprospecting for antibacterial drugs: a multidisciplinary perspective on natural product source material, bioassay selection and avoidable pitfalls","volume":"37","author":"Cushnie","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.micpath.2025.107361_bib86","series-title":"Understanding Pharmacology in Nursing Practice","article-title":"Antimicrobials","author":"Purssell","year":"2020"},{"issue":"2","key":"10.1016\/j.micpath.2025.107361_bib70","first-page":"377","article-title":"Multidrug-resistant bacteria in the community: trends and lessons learned","volume":"30","author":"Van Duin","year":"2016","journal-title":"Infectious disease clinics"},{"key":"10.1016\/j.micpath.2025.107361_bib71","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.csbj.2020.08.031","article-title":"CRISPR-Cas systems: overview, innovations and applications in human disease research and gene therapy","volume":"18","author":"Xu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.micpath.2025.107361_bib72","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/B978-0-12-820472-6.00041-4","article-title":"The role of natural products as sources of therapeutic agents for innovative drug discovery","author":"Dzobo","year":"2022","journal-title":"Comprehensive Pharmacology"},{"issue":"6","key":"10.1016\/j.micpath.2025.107361_bib73","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1039\/D1SC04471K","article-title":"Natural product drug discovery in the artificial intelligence era","volume":"13","author":"Sald\u00edvar-Gonz\u00e1lez","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.micpath.2025.107361_bib74","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2147\/IJN.S146195","article-title":"Nanotechnology-based drug delivery systems for control of microbial biofilms: a review","author":"Dos Santos Ramos","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2025.107361_bib75","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.2147\/IJN.S265934","article-title":"Recent advances in nanotechnology-aided materials in combating microbial resistance and functioning as antibiotics substitutes","author":"Munir","year":"2020","journal-title":"Int. J. Nanomed."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T14:43:03Z","timestamp":1740494583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":86,"alternative-id":["S0882401025000865"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107361","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107361"}}